Rifabutin labels and packages: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Rifabutin }} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MYCOBUTIN (RIFABUTIN) CAPSULE [PHARMACIA A..." |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{chetan}} | {{CMG}}; {{AE}} {{chetan}} | ||
Labels And Packages | |||
PRINCIPAL DISPLAY PANEL - 150 mg Capsule Label | |||
NDC 0013-5301-17 | |||
100 Capsules | |||
Rx only | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MYCOBUTIN (RIFABUTIN) CAPSULE [PHARMACIA AND UPJOHN COMPANY] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3e1a6613-bdd3-4261-93b3-d7f5cc09064b | publisher = | date = | accessdate }}</ref> | Mycobutin® | ||
rifabutin capsules, USP | |||
150 mg | |||
Pfizer | |||
Distributed by | |||
Pharmacia & Upjohn Co | |||
Division of Pfizer Inc, NY, NY 10017<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MYCOBUTIN (RIFABUTIN) CAPSULE [PHARMACIA AND UPJOHN COMPANY] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3e1a6613-bdd3-4261-93b3-d7f5cc09064b | publisher = | date = | accessdate }}</ref> | |||
Revision as of 00:13, 31 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Labels And Packages
PRINCIPAL DISPLAY PANEL - 150 mg Capsule Label
NDC 0013-5301-17
100 Capsules Rx only
Mycobutin® rifabutin capsules, USP
150 mg
Pfizer Distributed by Pharmacia & Upjohn Co Division of Pfizer Inc, NY, NY 10017[1]
References
- ↑ "MYCOBUTIN (RIFABUTIN) CAPSULE [PHARMACIA AND UPJOHN COMPANY]". Text " accessdate " ignored (help)
Adapted from the FDA Package Insert.